Expert Opinion on Emerging Drugs
Volume 29, 2024 - Issue 2
Open access
2,573
Views
0
CrossRef citations to date
0
Altmetric
Mini-review
Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis
Xiaoyan LiDepartment of Neurology, Duke University, Durham, NC, USAView further author information
& Richard BedlackDepartment of Neurology, Duke University, Durham, NC, USACorrespondence[email protected]
View further author information
View further author information
Pages 93-102
|
Received 19 Nov 2023, Accepted 18 Mar 2024, Published online: 22 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.